Skip to content
IceCure
DISTRIBUTORS
INVESTORS
  • Media
    • News
    • Events
    • Presentations
Menu
  • Media
    • News
    • Events
    • Presentations
U.S
INTERNATIONAL

You are now in the International site

  • Home
  • Company
    • About Us
    • Careers
  • Prosense System
    • User Manuals
  • Professionals
    • Breast Care
    • Interventional Radiology
    • ICE3 Trial
    • Fibroadenomas
    • Testimonials
    • Resources
  • Patients
    • Frequently Asked Questions
  • Contact Us
Menu
  • Home
  • Company
    • About Us
    • Careers
  • Prosense System
    • User Manuals
  • Professionals
    • Breast Care
    • Interventional Radiology
    • ICE3 Trial
    • Fibroadenomas
    • Testimonials
    • Resources
  • Patients
    • Frequently Asked Questions
  • Contact Us

Press Releases

Investors

Investors

  • Overview
  • News & Events
    • Press Releases
    • Events & Presentations
    • Email Alerts
  • Company Info
    • Management Team
    • Contacts
    • FAQ
  • Financial Results
  • Share Data
    • Quote
    • Charts
    • Historical Data
    • Analyst Coverage
  • SEC Filings
    • All SEC Filings
    • Annual Reports
  • Governance
    • Board of Directors
    • Board Committees
    • Governance Documents
    • Board Diversity Matrix
  • News & Events

  • Press Releases
  • Events & Presentations
  • Email Alerts
Mar 20, 2023 8:00am EDT

IceCure Medical to Report 2022 Full Year Financial & Operational Results on March 29, 2023

Feb 09, 2023 8:00am EST

IceCure Medical Announces Preliminary Unaudited 2022 Year-End Financial Results & Recent Operational Highlights

Jan 26, 2023 8:00am EST

IceCure's ProSense Featured in Breast Session at the Society of Interventional Oncology's Annual Scientific Meeting in Washington, D.C.

Jan 25, 2023 8:00am EST

IceCure's ProSense Presented in Hands-On Training Course at The American Society of Breast Surgeons Breast Follows Ultrasound Course

Jan 23, 2023 8:00am EST

U.S. Patent Office Grants Notice of Allowance to IceCure for Novel Cryogenic Pump for Next-Generation Cryoablation Systems

Jan 18, 2023 8:00am EST

IceCure Receives Notice of Patent Allowance in Japan for a Novel Cryogenic Pump for its Next-Generation Cryoablation Systems

Jan 04, 2023 8:00am EST

IceCure Medical CEO Issues Letter to Shareholders

Dec 23, 2022 4:00pm EST

IceCure Medical Ltd. Announces Closing of $14.5 Million Public Offering Priced At-The-Market Under Nasdaq Rules

Dec 21, 2022 9:00am EST

IceCure Medical Ltd. Announces Pricing of $14.5 Million Public Offering Priced At-The-Market Under Nasdaq Rules

Dec 20, 2022 4:00pm EST

IceCure Medical Ltd. Announces Proposed Public Offering

  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • arrow_forward
rss_feed News RSS
  • Email Alerts
  • Contacts
  • RSS News Feed
IceCure

IceCure Medical E: icecuresupport@icecure-medical.com
HQ: 7 Ha’Eshel St., PO Box 3163, Caesarea, 3079504, Israel

PRIVACY POLICY | TERMS & CONDITIONS

Last Updated November 23, 2021

Facebook Twitter Linkedin Youtube

HOME

COMPANY

  • About Us
  • Careers
Menu
  • About Us
  • Careers

PROSENSE SYSTEM

PROFESSIONALS

  • Breast Care
  • Interventional Radiology
  • ICE3 Trial
  • Fibroadenomas
  • Testimonials
Menu
  • Breast Care
  • Interventional Radiology
  • ICE3 Trial
  • Fibroadenomas
  • Testimonials

PATIENTS

  • Frequently Asked Questions
Menu
  • Frequently Asked Questions

CONTACT US

Copyright IceCure Medical © 2023
Scroll to the top of the page